These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28266084)

  • 1. Recommendations for the evaluation of complex genetic toxicity data sets when assessing carcinogenic risks to humans.
    Eastmond DA
    Environ Mol Mutagen; 2017 Jun; 58(5):380-385. PubMed ID: 28266084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical review of styrene genotoxicity focused on the mutagenicity/clastogenicity literature and using current organization of economic cooperation and development guidance.
    Moore MM; Pottenger LH; House-Knight T
    Environ Mol Mutagen; 2019 Aug; 60(7):624-663. PubMed ID: 30786062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites.
    Galloway SM
    Environ Mol Mutagen; 2017 Jun; 58(5):296-324. PubMed ID: 28299826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity testing approaches for the safety assessment of substances used in food contact materials prior to their authorization in the European Union.
    Bolognesi C; Castoldi AF; Crebelli R; Barthélémy E; Maurici D; Wölfle D; Volk K; Castle L
    Environ Mol Mutagen; 2017 Jun; 58(5):361-374. PubMed ID: 28556235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches for identifying germ cell mutagens: Report of the 2013 IWGT workshop on germ cell assays(☆).
    Yauk CL; Aardema MJ; Benthem Jv; Bishop JB; Dearfield KL; DeMarini DM; Dubrova YE; Honma M; Lupski JR; Marchetti F; Meistrich ML; Pacchierotti F; Stewart J; Waters MD; Douglas GR
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():36-54. PubMed ID: 25953399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety assessment and global regulatory requirements for genetic toxicity evaluations of medical devices.
    Przygoda RT
    Environ Mol Mutagen; 2017 Jun; 58(5):375-379. PubMed ID: 28573657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a next generation framework for assessment of genomic damage: A case study using the industrial chemical benzene.
    Luijten M; Ball NS; Dearfield KL; Gollapudi BB; Johnson GE; Madia F; Peel L; Pfuhler S; Settivari RS; Ter Burg W; White PA; van Benthem J
    Environ Mol Mutagen; 2020 Jan; 61(1):94-113. PubMed ID: 31709603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
    Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
    Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative.
    Thybaud V; Aardema M; Casciano D; Dellarco V; Embry MR; Gollapudi BB; Hayashi M; Holsapple MP; Jacobson-Kram D; Kasper P; MacGregor JT; Rees R
    Mutat Res; 2007 Oct; 633(2):67-79. PubMed ID: 17616430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
    Cimino MC
    Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity of airborne PM
    Bocchi C; Bazzini C; Fontana F; Pinto G; Cassoni F
    Environ Mol Mutagen; 2017 Dec; 58(9):719-729. PubMed ID: 29023966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk.
    MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Johnson GE; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():66-78. PubMed ID: 25953401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.